Assessing Response Profiles from Incomplete Longitudinal Clinical Trial Data Under Regulatory Considerations
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Treatment effects are often evaluated by comparing change over time in outcome measures. However, valid analyses of longitudinal data can be problematic, particularly when some data are missing for reasons related to the outcome. In choosing the primary analysis for confirmatory clinical trials, regulatory agencies have for decades favored the last observation carried forward (LOCF) approach for imputing missing values. Many advances in statistical methodology, and also in our ability to implement those methods, have been made in recent years. The characteristics of data from acute phase clinical trials can be exploited to develop an appropriate analysis for assessing response profiles in a regulatory setting. These data characteristics and regulatory considerations will be reviewed. Approaches for handling missing data are compared along with options for modeling time effects and correlations between repeated measurements. Theory and empirical evidence are utilized to support the proposal that likelihood-based mixed-effects model repeated measures (MMRM) approaches, based on the missing at random assumption, provide superior control of Type I and Type II errors when compared with the traditional LOCF approach, which is based on the more restrictive missing completely at random assumption. It is further reasoned that in acute phase clinical trials, unstructured modeling of time trends and within-subject error correlations may be preferred.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Linear Mixed Models for Longitudinal Data
Verbeke, G. (1997) · Lecture Notes in Statistics · doi:10.1007/978-1-4612-2294-1_3 · Cited by 3,506
ACCOUNTING FOR DROPOUT BIAS USING MIXED-EFFECTS MODELS
Mallinckrodt, C. H., Clark, W. S., & David, S. R. (2001) · Journal of Biopharmaceutical Statistics · doi:10.1081/bip-100104194 · Cited by 398 · cited 8×
“The simulation studies cited herein (Mallinckrodt et al., 2001a,b) illustrated, and other authors have noted (Lavori, 1992; Little and Yau, 1996; Molenberghs et al., 2002; Verbeke and Molenberghs, 2000), that conservative behavior of LOCF is not guaranteed.”
BackgroundMethodResultInfluentialSelf-citationDuloxetine in the Treatment of Major Depressive Disorder: A Double-Blind Clinical Trial
Goldstein, D. J., Mallinckrodt, C., Lu, Y., & Demitrack, M. A. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0309 · Cited by 334 · cited 3×
“Results of the subsequent trial were summarized by Goldstein et al. Post-hoc analyses of the subsequent trial again provided strong evidence for violation of the MCAR assumptions.”
BackgroundSelf-citationGoldstein, D. J., Lu, Y., Detke, M. J., Wiltse, C., Mallinckrodt, C., & Demitrack, M. A. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000132448.65972.d9 · Cited by 314
Self-citation
Cited by
Gueorguieva, R., & Krystal, J. H. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.3.310 · Cited by 1,529
Smith, G. E., Housen, P., Yaffe, K., Ruff, R., Kennison, R. F., Mahncke, H. W., & Zelinski, E. M. (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.02167.x · Cited by 785
Analyzing incomplete longitudinal clinical trial data
Molenberghs, G. (2004) · Biostatistics · doi:10.1093/biostatistics/5.3.445 · Cited by 463
Self-citationDifferential dropout and bias in randomised controlled trials: when it matters and when it may not
Bell, M. L., Kenward, M. G., Fairclough, D. L., & Horton, N. J. (2013) · BMJ · doi:10.1136/bmj.e8668 · Cited by 460
Kolterman, O. G., Kim, D. D., Shen, L., Ruggles, J. A., Nielsen, L. L., Fineman, M. S., & Baron, A. D. (2005) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/62.2.173 · Cited by 434
Metadata
- Authors
- Mallinckrodt, C. H., Clark, W. S., Carroll, R. J., & Molenberghs, G.
- Venue
- Journal of Biopharmaceutical Statistics
- Publisher
- Informa UK Limited
- Published
- 2003-01-04
- Volume
- 13
- Issue
- 2
- Pages
- 179-190
- ISSN
- 1054-3406 (ISSN-L)
- 1520-5711
- OpenAlex
- W2091679283
- Cited by
- 138
- References
- 4
- FWCI
- 10.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Assessing Response Profiles from Incomplete Longitudinal Clinical Trial Data Under Regulatory Considerations. https://app.cochat.ai/papers/10.1081/bip-120019265
- The paper
- Mallinckrodt, C. H., Clark, W. S., Carroll, R. J., & Molenberghs, G. (2003). Assessing Response Profiles from Incomplete Longitudinal Clinical Trial Data Under Regulatory Considerations. Journal of Biopharmaceutical Statistics. https://doi.org/10.1081/bip-120019265
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.